During the recent session, Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s traded shares were 6.84 million, with the beta value of the company hitting 1.95. At the last check today, the stock’s price was $1.13, reflecting an intraday loss of -2.59% or -$0.03. The 52-week high for the MIRA share is $5.01, that puts it down -343.36 from that peak though still a striking 54.87% gain since the share price plummeted to a 52-week low of $0.51. The company’s market capitalization is $19.00M, and the average trade volume was 1.17 million shares over the past three months.

Mira Pharmaceuticals Inc (NASDAQ:MIRA) trade information

Mira Pharmaceuticals Inc (MIRA) registered a -2.59% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.59% in intraday trading to $1.13, hitting a weekly high. The stock’s 5-day price performance is -0.88%, and it has moved by 36.14% in 30 days. Based on these gigs, the overall price performance for the year is 50.67%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -224.25%. While earnings are projected to return 14.29% in 2025.

MIRA Dividends

Mira Pharmaceuticals Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Mira Pharmaceuticals Inc (MIRA) shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund owns about 117.82 shares. This amounts to just over 0.70 percent of the company’s overall shares, with a $0.12 million market value. The same data shows that the other fund manager holds slightly less at 68.72, or about 0.41% of the stock, which is worth about $72847.0.